Risedronic Acid
Who holds supplier records for Risedronic Acid? 7 organisations hold a current record for Risedronic Acid: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6) and Canada (1).
Most records are filed under another form of this substance: Risedronate Sodium (11 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Risedronic Acid: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/risedronic-acid
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Risedronic Acid expires 9 Jan 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Risedronic Acid. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 21121 · latest filing Dec 2007
- Apotex Inc.CanadaActive DMF 21819 · latest filing Jul 2008
- Cipla LimitedIndia Company GMP cert on recordActive DMF 20162 · latest filing Mar 2007
- Ipca Laboratories LimitedIndia Company GMP cert on recordActive DMF 23759, 27252 · latest filing Jul 2013
- JUBILANT BIOSYS LTDIndiaActive DMF 19968 · latest filing Nov 2006
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 21529 · latest filing May 2008
- SYNTHIMED LABS PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 21033 · latest filing Oct 2007
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Risedronic Acid are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- India · Inactive DMF 27197 · filed May 2013
- PHARMAZELL VIZAG PRIVATE LTDInactive DMF 25007 · filed Jun 2011
- India · Inactive DMF 21447 · filed Mar 2008
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (25 listed products contain Risedronic Acid). The latest listed patent expires 9 Jan 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Risedronic Acid is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL923).
Chemical identity
- IUPAC name
- (1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid
- Canonical SMILES
- C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
- InChIKey
- IIDJRNMFWXDHID-UHFFFAOYSA-N
- Synonyms
- Acide risedronique, Acido risedronico, M05BA07, Ridron, Risedronate, Risedronic acid, Acidum risedronicum, RefChem:56783, Risedronic acid monohydrate, Benet, Sodium risedronate, Risedronic acid (INN)
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Risedronic Acid?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Risedronic Acid: APITORIA PHARMA PRIVATE LTD (India), Apotex Inc. (Canada), Cipla Limited (India), Ipca Laboratories Limited (India), JUBILANT BIOSYS LTD (India), Sun Pharmaceutical Industries Limited (India) and SYNTHIMED LABS PRIVATE LIMITED (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Risedronic Acid Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 21121), Apotex Inc. (DMF 21819), Cipla Limited (DMF 20162), Ipca Laboratories Limited (DMF 23759, 27252), JUBILANT BIOSYS LTD (DMF 19968), Sun Pharmaceutical Industries Limited (DMF 21529) and SYNTHIMED LABS PRIVATE LIMITED (DMF 21033). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Risedronic Acid records mean?
3 organisations have only inactive Type II DMFs for Risedronic Acid. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Risedronic Acid?
Yes. The latest patent listed for an approved US product containing Risedronic Acid expires 9 Jan 2028, across 25 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Risedronic Acid supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Risedronic Acid?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.